ASCO 2023: Bispecific Post-Conference Report

Beacon Bispecific experts have screened each abstract from the 2023 ASCO Annual Meeting, held on 2nd to 6th June. This year, 110 bispecific-relevant abstracts (107 clinical and 3 preclinical) were identified and have been listed in order of presentation in our Post-Conference Report.

ASCO 2023: Bispecific Abstract Highlights

The ASCO Post-Conference Report sample includes additional analysis and insight from our Beacon Bispecific experts as well as a list of all bispecific-relevant abstracts.

You May Also Be Interested In…

Learn More About Bispecific

What is Beacon Bispecific?
  • The Most Comprehensive Way to Search the Bispecific Drug Development Landscape: Unique search ontologies based on Bispecific drug and trial characteristics
  • Market Leading Approach to Bispecific Preclinical & Clinical Data Curation: Manual curation of key Bispecific research and development data points Bispecific research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Bispecific company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Bispecific

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search